Skip to main
AVIR
AVIR logo

Atea Pharmaceuticals (AVIR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Atea Pharmaceuticals (AVIR) Stock

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Market cap$308.09M
Today's volume390.16K
Revenue (TTM)
Avg. daily volume432.56K
EBITDA (TTM)-$161.77M
Open$3.57
Price / earnings ratio-2.18x
Today's range$3.54 - $3.65
Debt / equity0.35x
52 week range$2.46 - $4.15
5 year debt / equity0.17x
Beta (LTM)0.77x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio19.94x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Atea Pharmaceuticals Stock Rating

What analysts recommend for AVIR stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for AVIR stock is $308.09M

The current P/E ratio for AVIR stock is -2.18

The 52-week high for AVIR stock is $4.15. The current AVIR stock price $undefined is 100.00% below its 52-week high

The 52-week low for AVIR stock is $2.46. The current AVIR stock price $undefined has increased 100.00% from its 52-week low

No, the AVIR stock does not pay dividends to its shareholders

The target price for AVIR stock is $6.67 based on the average of what a group of analyst think AVIR stock could be worth at a future date. This is not a prediction by Public.com

How to buy AVIR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AVIR stock

    Navigate to the Explore page. Then, type AVIR into the search bar. When you see AVIR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AVIR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Atea Pharmaceuticals Stock Earnings

The value each AVIR share was expected to gain vs. the value that each AVIR share actually gained.

Atea Pharmaceuticals (AVIR) reported Q1 2025 earnings per share (EPS) of -$0.40, beating estimates of -$0.41 by 2.44%. In the same quarter last year, Atea Pharmaceuticals's earnings per share (EPS) was -$0.75. Atea Pharmaceuticals is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$0.41.

Buy Atea Pharmaceuticals (AVIR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.